ScholarWorks@Dongguk University

Browsing by Hong, ChangheeAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 2 of 2

SCIESCOPUS
Lower hepatotoxicity risk in Xelaglifam, a novel GPR40 agonist, compared to Fasiglifam for type 2 diabetes therapyopen access

Yoon, Jongmin; Song, Haengjin; Park, Ji Soo; Kim, Jeong Ho; Jun, Yearin; Gim, Sang-Ah; Hong, Changhee; An, Kyung Mi; Park, Joon-Tae; Lee, Jung Woo, et al.

ArticleIssue Date2024CitationBiomedicine and Pharmacotherapy, v.181, pp 1 - 14PublisherElsevier Masson SAS
SCIESCOPUS
Xelaglifam, a novel GPR40/FFAR1 agonist, exhibits enhanced β-arrestin recruitment and sustained glycemic control for type 2 diabetesopen access

Yoon, Jongmin; Lee, Don-Gil; Song, Haengjin; Hong, Dahae; Park, Ji Soo; Hong, Changhee; An, Kyung Mi; Lee, Jung Woo; Park, Joon-Tae; Yoon, Hongchul, et al.

ArticleIssue Date2024CitationBiomedicine and Pharmacotherapy, v.177, pp 1 - 17PublisherElsevier Masson SAS
1
CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114

Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어